Corient Capital Partners’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | $923K | Buy |
13,966
+2,318
| +20% | +$153K | 0.07% | 230 |
|
2022
Q2 | $770K | Sell |
11,648
-25,417
| -69% | -$1.68M | 0.06% | 262 |
|
2022
Q1 | $2.46M | Sell |
37,065
-2,103
| -5% | -$140K | 0.16% | 133 |
|
2021
Q4 | $2.28M | Sell |
39,168
-7,398
| -16% | -$431K | 0.15% | 138 |
|
2021
Q3 | $2.8M | Buy |
46,566
+3,578
| +8% | +$215K | 0.2% | 108 |
|
2021
Q2 | $2.58M | Sell |
42,988
-37
| -0.1% | -$2.22K | 0.19% | 116 |
|
2021
Q1 | $2.14M | Sell |
43,025
-20,452
| -32% | -$1.02M | 0.18% | 115 |
|
2020
Q4 | $3.17M | Buy |
63,477
+6,543
| +11% | +$327K | 0.32% | 77 |
|
2020
Q3 | $3.12M | Sell |
56,934
-2,154
| -4% | -$118K | 0.36% | 67 |
|
2020
Q2 | $3.13M | Buy |
59,088
+5,148
| +10% | +$272K | 0.38% | 64 |
|
2020
Q1 | $2.41M | Buy |
53,940
+1,702
| +3% | +$76K | 0.38% | 66 |
|
2019
Q4 | $2.6M | Buy |
52,238
+770
| +1% | +$38.4K | 0.33% | 70 |
|
2019
Q3 | $2.29M | Buy |
51,468
+6,837
| +15% | +$305K | 0.32% | 70 |
|
2019
Q2 | $1.84M | Buy |
44,631
+2,342
| +6% | +$96.7K | 0.28% | 86 |
|
2019
Q1 | $1.71M | Sell |
42,289
-3,583
| -8% | -$145K | 0.28% | 104 |
|
2018
Q4 | $1.74M | Sell |
45,872
-41,037
| -47% | -$1.56M | 0.31% | 94 |
|
2018
Q3 | $3.44M | Hold |
86,909
| – | – | 0.57% | 37 |
|
2018
Q2 | $3.05M | Sell |
86,909
-49,826
| -36% | -$1.75M | 0.53% | 42 |
|
2018
Q1 | $4.78M | Sell |
136,735
-20,700
| -13% | -$724K | 0.88% | 18 |
|
2017
Q4 | $5.46M | Buy |
157,435
+6,441
| +4% | +$224K | 0.93% | 20 |
|
2017
Q3 | $5.12M | Sell |
150,994
-14,430
| -9% | -$489K | 0.97% | 19 |
|
2017
Q2 | $5.64M | Sell |
165,424
-7,171
| -4% | -$244K | 0.86% | 27 |
|
2017
Q1 | $5.38M | Buy |
172,595
+150,796
| +692% | +$4.7M | 0.84% | 29 |
|
2016
Q4 | $596K | Sell |
21,799
-111,352
| -84% | -$3.04M | 0.11% | 179 |
|
2016
Q3 | $4.38M | Buy |
+133,151
| New | +$4.38M | 0.81% | 29 |
|